These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6900630)

  • 1. Bu-2313, a new antibiotic complex active against anaerobes. III. Semi-synthesis of Bu-2313 A and B, and their analogs.
    Toda S; Nakagawa S; Naito T; Kawaguchi H
    J Antibiot (Tokyo); 1980 Feb; 33(2):173-81. PubMed ID: 6900630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bu-2313, a new antibiotic complex active against anaerobes. I. Production, isolation and properties of Bu-2313 A and B.
    Tsukiura H; Tomita K; Hanada M; Kobaru S; Tsunakawa M; Fujisawa K; Kawaguchi H
    J Antibiot (Tokyo); 1980 Feb; 33(2):157-65. PubMed ID: 6900628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bu-2313, a new antibiotic complex active against anaerobes. II. Structure determination of Bu-2313 A and B.
    Tsunakawa M; Toda S; Okita T; Hanada M; Nakagawa S; Tsukiura H; Naito T; Kawaguchi H
    J Antibiot (Tokyo); 1980 Feb; 33(2):166-72. PubMed ID: 6900629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of BU-2313B against anaerobic bacteria.
    Bansal MB; Dhawan VK; Thadepalli H
    Chemotherapy; 1982; 28(3):200-3. PubMed ID: 6920296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and in vitro activity of new semi-synthetic coumermycin analogs: chemical modification at the C-3 amide.
    Ueda Y; Chuang JM; Crast LB; Partyka RA
    J Antibiot (Tokyo); 1989 Sep; 42(9):1379-92. PubMed ID: 2793593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective N-actylation of gentamicin antibiotics-synthesis of 1-N-acyl derivatives.
    Wright JJ; Cooper A; Daniels PJ; Nagabhushan TL; Rane D; Turner WN; Weinstein J
    J Antibiot (Tokyo); 1976 Jul; 29(7):714-9. PubMed ID: 8416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of 6'- and 6'''-N-acylation of aminoglycosides as a strategy to overcome bacterial resistance.
    Shaul P; Green KD; Rutenberg R; Kramer M; Berkov-Zrihen Y; Breiner-Goldstein E; Garneau-Tsodikova S; Fridman M
    Org Biomol Chem; 2011 Jun; 9(11):4057-63. PubMed ID: 21365081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. synthesis of 2-deoxyfortimicins and 1-deamino-2-deoxy-2-epi-aminofortimicins via 2-O-methanesulfonylfortimicin B.
    Martin JR; Johnson P; Tadanier J; Goldstein AW
    J Antibiot (Tokyo); 1980 Aug; 33(8):810-8. PubMed ID: 7429983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic X-5108. IX. Chemical conversion of mocimycin to aurodox and derivatives of aurodox, goldinamine and mocimycin.
    Maehr H; Leach M; Yarmchuk L; Mitrovic M
    J Antibiot (Tokyo); 1979 Apr; 32(4):361-7. PubMed ID: 381270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-N-acylfortimicins B and the preparation of fortimicin A from fortimicin B.
    Tadanier J; Martin JR; Kurath P; Goldstein AW; Johnson P
    Carbohydr Res; 1980 Feb; 79(1):91-102. PubMed ID: 7357570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syntheses of sporaricin analogues, 2-deoxy-4-N-glycyl-6-O-(alpha-nebrosaminyl)fortamine and its 3-de-O-methyl compound.
    Yamaguchi T; Kyotani Y; Watanabe I; Sato S; Takahashi Y; Nagakura M; Mori T
    J Antibiot (Tokyo); 1979 Nov; 32(11):1137-46. PubMed ID: 528383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical modification of sorbistin. I. N-acyl analogs of sorbistin.
    Naito T; Nakagawa S; Narita Y; Kawaguchi H
    J Antibiot (Tokyo); 1976 Dec; 29(12):1286-96. PubMed ID: 1010799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and properties of derivatives at the amino group of ristocetin aglycone.
    Kobrin MB; Katrukha HS; Fedorova GB
    J Antibiot (Tokyo); 1989 Sep; 42(9):1441-2. PubMed ID: 2507496
    [No Abstract]   [Full Text] [Related]  

  • 14. Structure and biological activity of lipiarmycin B.
    Cavalleri B; Arnone A; Di Modugno E; Nasini G; Goldstein BP
    J Antibiot (Tokyo); 1988 Mar; 41(3):308-15. PubMed ID: 3366689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4-N-Aminoacylation of substances derived from lysinomicin.
    Kurath P; Stanaszek RS; Cirovic M
    J Antibiot (Tokyo); 1982 Oct; 35(10):1338-44. PubMed ID: 7174518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antibacterial activity of lactivicin derivatives.
    Tamura N; Matsushita Y; Kawano Y; Yoshioka K
    Chem Pharm Bull (Tokyo); 1990 Jan; 38(1):116-22. PubMed ID: 2337934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in vitro antibacterial activity of a new series of monobactam derivatives.
    Valcavi U; Aveta R; Brandt A; Corsi GB; Bosone E; Farina P; Guazzi G
    Farmaco Sci; 1988 Jun; 43(6):559-66. PubMed ID: 3208898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical modification of fortimicins: preparation of 4-N-substituted fortimicin B.
    Sato M; Mori Y
    J Antibiot (Tokyo); 1979 Apr; 32(4):371-8. PubMed ID: 468724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semi-synthesis of polymyxin B (2-10) and colistin (2-10) analogs employing the Trichloroethoxycarbonyl (Troc) group for side chain protection of alpha,gamma-diaminobutyric acid residues.
    Okimura K; Ohki K; Sato Y; Ohnishi K; Sakura N
    Chem Pharm Bull (Tokyo); 2007 Dec; 55(12):1724-30. PubMed ID: 18057747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical modification of fortimicins. III. preparation of N-substituted fortimicin A derivatives.
    Mochida K; Sato M; Yoshiie S; Mori Y; Shirahata K; Kitaura K
    J Antibiot (Tokyo); 1981 May; 34(5):522-9. PubMed ID: 7275834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.